BlackRock Investment Management’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $3.8M | Sell |
182,686
-5,984
| -3% | -$124K | ﹤0.01% | 1779 |
|
|
2016
Q3 | $6.18M | Buy |
188,670
+1,610
| +0.9% | +$52.8K | 0.01% | 1334 |
|
|
2016
Q2 | $4.67M | Buy |
187,060
+93,980
| +101% | +$2.35M | 0.01% | 1479 |
|
|
2016
Q1 | $2.28M | Sell |
93,080
-16,745
| -15% | -$410K | ﹤0.01% | 1897 |
|
|
2015
Q4 | $3.63M | Buy |
109,825
+1,008
| +0.9% | +$33.3K | ﹤0.01% | 1623 |
|
|
2015
Q3 | $3.57M | Buy |
108,817
+1,519
| +1% | +$49.8K | ﹤0.01% | 1619 |
|
|
2015
Q2 | $5.68M | Buy |
107,298
+42,441
| +65% | +$2.25M | 0.01% | 1400 |
|
|
2015
Q1 | $1.87M | Buy |
64,857
+24,677
| +61% | +$712K | ﹤0.01% | 2071 |
|
|
2014
Q4 | $1.17M | Buy |
40,180
+480
| +1% | +$14K | ﹤0.01% | 2437 |
|
|
2014
Q3 | $503K | Buy |
39,700
+115
| +0.3% | +$1.46K | ﹤0.01% | 2963 |
|
|
2014
Q2 | $794K | Buy |
+39,585
| New | +$794K | ﹤0.01% | 2765 |
|